Capped Zinc Oxide Nanoparticles Induce Apoptosis in MCF-7 Breast Cancer Cells
Affiliations
(RF) has widely been used to treat various ailments, including pain, diabetes, and cancer. Zinc oxide nanoparticles (ZnO NPs) have drawn attention in modern healthcare applications. Hence, we designed this study to synthesize zinc oxide (ZnO) nanoparticles using root extract to investigate its synergistic cytotoxic effect on MCF-7 cells and explore the possible cell death mechanism. ZnO NPs were synthesized via green synthesis using root extract, and the effect on MCF-7 cells was determined by looking at cellular morphology, proliferation, cytotoxicity, apoptosis, and reactive oxygen species (ROS). The results showed that cellular proliferation was reduced following treatment with capped zinc oxide nanoparticles (RFZnO NPs), while cytotoxicity and ROS were increased. There was also an increase in apoptosis as indicated by the significant increase in cytoplasmic cytochrome c and caspase 3/7 (markers of apoptosis), as well as increased levels of pro-apoptotic proteins (p53, Bax) and decreased levels of anti-apoptotic protein (Bcl-2). In conclusion, these results showed that RFZnO NPs induce apoptosis in breast cancer cells via a mitochondria-mediated caspase-dependent apoptotic pathway and suggest the use of acetone root extract of for the treatment of cancer-related ailments.
Synthesis of Zinc Oxide-Doped Carbon Dots for Treatment of Triple-Negative Breast Cancer.
Wang M, Lan S, Song M, Zhang R, Zhang W, Sun X Int J Nanomedicine. 2025; 19:13949-13971.
PMID: 39742095 PMC: 11687324. DOI: 10.2147/IJN.S494262.
Green synthesized -ZnO nanoparticles: anticancer efficacy against 3D breast cancer model.
Alhaddad R, Abualsoud B, Al-Deeb I, Nsairat H Future Sci OA. 2024; 10(1):2419806.
PMID: 39539163 PMC: 11572278. DOI: 10.1080/20565623.2024.2419806.
Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives.
Luobin L, Wanxin H, Yingxin G, Qinzhou Z, Zefeng L, Danyang W Cell Death Discov. 2024; 10(1):386.
PMID: 39209834 PMC: 11362291. DOI: 10.1038/s41420-024-02121-0.
Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities.
Rezaei H, Iranbakhsh A, Sepahi A, Mirzaie A, Larijani K Sci Rep. 2024; 14(1):16692.
PMID: 39030347 PMC: 11271597. DOI: 10.1038/s41598-024-67509-5.
Xu J, Yu C, Zeng X, Tang W, Xu S, Tang L Eur J Med Res. 2023; 28(1):461.
PMID: 37885035 PMC: 10605986. DOI: 10.1186/s40001-023-01364-4.